Literature DB >> 32288183

Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes.

B Charley1, H Laude1, C La Bonnardière1.   

Abstract

In vitro studies were undertaken to examine the effects of non-immune porcine peripheral blood leukocytes (PBL) on a Coronavirus infection due to transmissible gastroenteritis virus (TGEV). The assay consisted of TGEV-infected epithelial cells expressing viral antigens on the cell surface and producing low amounts of interferon (IFN). Non-immune PBL were found to limit virus replication at an effector-to-target ratio of 100/1 even when effector cells were depleted of phagocytic cells. Neutralizing anti-IFN antibodies did not abrogate the effect. PBL from newborn animals were as effective as adult cells, whereas fibroepithelial cells, human and mouse lymphoid cells did not exert antiviral effects. Under similar conditions, PBL from adult animals could lyse TGEV-infected cells even in the presence of anti-IFN antibodies. However, newborn PBL were not cytotoxic. Moreover, depletion of NK cells by monoclonal antibodies plus complement did not alter the inhibitory effect. These latter observations suggest that virus multiplication-inhibition effects and cytotoxic (or NK) activities are unrelated.
Copyright © 1987 Published by Elsevier Masson SAS.

Entities:  

Keywords:  Coronavirus, TGEV, Cytotoxicity, Lymphocyte; Interferon, Pig

Year:  2009        PMID: 32288183      PMCID: PMC7134748          DOI: 10.1016/S0769-2617(87)80003-5

Source DB:  PubMed          Journal:  Ann Inst Pasteur Virol        ISSN: 0769-2617


  30 in total

1.  Specificity of pig T lymphocyte antiserum: cytotoxicity and inhibiting properties onto E-rosette-forming lymphocytes.

Authors:  H Salmon
Journal:  Ann Immunol (Paris)       Date:  1978 Apr-Jun

2.  Activated macrophages mediate interferon-independent inhibition of herpes simplex virus.

Authors:  S S Morse; P S Morahan
Journal:  Cell Immunol       Date:  1981-02       Impact factor: 4.868

3.  High interferon titer in newborn pig intestine during experimentally induced viral enteritis.

Authors:  C La Bonnardiere; H Laude
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

4.  In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins.

Authors:  D J Arora; M Houde; D M Justewicz; R Mandeville
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

5.  Natural killing and antibody-dependent cellular cytotoxicity in specific-pathogen-free miniature swine and germ-free piglets. II. Ontogenic development development of NK and ADCC.

Authors:  N D Huh; Y B Kim; H S Koren; D B Amos
Journal:  Int J Cancer       Date:  1981-08-15       Impact factor: 7.396

6.  Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance.

Authors:  M Tardieu; C Héry; J M Dupuy
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

7.  Preparation and characterization of monoclonal antibodies reactive with porcine PBL.

Authors:  M D Pescovitz; J K Lunney; D H Sachs
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  Characterization of monoclonal antibodies directed against swine leukocytes.

Authors:  C Hammerberg; G G Schurig
Journal:  Vet Immunol Immunopathol       Date:  1986-02       Impact factor: 2.046

9.  Interferon induction in rotavirus and coronavirus infections: a review of recent results.

Authors:  C La Bonnardière; H Laude
Journal:  Ann Rech Vet       Date:  1983

10.  In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon.

Authors:  P Casali; J G Sissons; M J Buchmeier; M B Oldstone
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine.

Authors:  L J Saif; J L van Cott; T A Brim
Journal:  Vet Immunol Immunopathol       Date:  1994-10       Impact factor: 2.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.